BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi JQ, Wang BR, Jiang T, Gao L, Zhang YD, Xu J. NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease. J Alzheimers Dis 2020;77:923-34. [PMID: 32804134 DOI: 10.3233/JAD-200359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv J, Shen X, Shen X, Li X, Jin Z, Ouyang X, Lu J, Zhu D, Wang J, Shen X. Miltefosine as a PPM1A activator improves AD-like pathology in mice by alleviating tauopathy via microglia/neurons crosstalk. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100546] [Reference Citation Analysis]
2 Castellani B, Bartington S, Wistow J, Heckels N, Ellison A, Van Tongeren M, Arnold SR, Barbrook-Johnson P, Bicket M, Pope FD, Russ TC, Clarke CL, Pirani M, Schwannauer M, Vieno M, Turnbull R, Gilbert N, Reis S. Mitigating the impact of air pollution on dementia and brain health: Setting the policy agenda. Environ Res 2022;215:114362. [PMID: 36130664 DOI: 10.1016/j.envres.2022.114362] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gao L, Qin JX, Shi JQ, Jiang T, Wang F, Xie C, Gao Q, Zhi N, Dong Q, Guan YT. Fine particulate matter exposure aggravates ischemic injury via NLRP3 inflammasome activation and pyroptosis. CNS Neurosci Ther 2022;28:1045-58. [PMID: 35403328 DOI: 10.1111/cns.13837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yuan H, Lu B, Ji Y, Meng B, Wang R, Sun D, Liu R, Zhai X, Li X, Qin J, Chen J, Coutinho-silva R. Role of P2X4/NLRP3 Pathway-Mediated Neuroinflammation in Perioperative Neurocognitive Disorders. Mediators of Inflammation 2022;2022:1-9. [DOI: 10.1155/2022/6355805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]